282 related articles for article (PubMed ID: 26544755)
21. Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis.
Cha YJ; Park EJ; Baik SH; Lee KY; Kang J
PLoS One; 2019; 14(3):e0214415. PubMed ID: 30901357
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
Wang P; Wang Z; Liu Y; Xie J; Ren Y
Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Stage I-II Rectal Cancer Patients.
Yoshida D; Minami K; Sugiyama M; Ota M; Ikebe M; Morita M; Matsukuma A; Toh Y
J Surg Res; 2020 Jan; 245():281-287. PubMed ID: 31421374
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancer.
Huang CS; Lin JK; Wang LW; Liang WY; Lin CC; Lan YT; Wang HS; Yang SH; Jiang JK; Chen WS; Lin TC; Chang SC
Am J Surg; 2014 Jul; 208(1):99-105. PubMed ID: 24524862
[TBL] [Abstract][Full Text] [Related]
27. Can Haematology Blood Tests at Time of Diagnosis Predict Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer?
Ramsay G; Ritchie DT; MacKay C; Parnaby C; Murray G; Samuel L
Dig Surg; 2019; 36(6):495-501. PubMed ID: 30269129
[TBL] [Abstract][Full Text] [Related]
28. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
[TBL] [Abstract][Full Text] [Related]
29. Neutrophil-Lymphocyte Ratio as a Prognostic Marker for Lung Adenocarcinoma After Complete Resection.
Takahashi Y; Kawamura M; Hato T; Harada M; Matsutani N; Horio H
World J Surg; 2016 Feb; 40(2):365-72. PubMed ID: 26493696
[TBL] [Abstract][Full Text] [Related]
30. The Neutrophil-to-Lymphocyte Ratio as a Marker of Lymph Node Status in Patients with Rectal Cancer.
Khan AA; Akritidis G; Pring T; Alagarathnam S; Roberts G; Raymond R; Varcada M; Novell R
Oncology; 2016; 91(2):69-77. PubMed ID: 27288007
[TBL] [Abstract][Full Text] [Related]
31. Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma.
Ward WH; Goel N; Ruth KJ; Esposito AC; Lambreton F; Sigurdson ER; Meyer JE; Farma JM
J Surg Res; 2018 Dec; 232():275-282. PubMed ID: 30463730
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer.
Kim IY; You SH; Kim YW
BMC Surg; 2014 Nov; 14():94. PubMed ID: 25406793
[TBL] [Abstract][Full Text] [Related]
33. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
[TBL] [Abstract][Full Text] [Related]
34. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction.
Yuan D; Zhu K; Li K; Yan R; Jia Y; Dang C
J Surg Oncol; 2014 Sep; 110(3):333-40. PubMed ID: 24889121
[TBL] [Abstract][Full Text] [Related]
35. Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy.
Yeo SG; Kim DY; Chang HJ; Park JW; Oh JH; Kim BC; Baek JY; Kim SY; Kim TH
Tumori; 2013; 99(1):93-9. PubMed ID: 23549007
[TBL] [Abstract][Full Text] [Related]
36. Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy.
Kim TG; Park W; Kim H; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Kang KM
Tumori; 2019 Oct; 105(5):434-440. PubMed ID: 30117371
[TBL] [Abstract][Full Text] [Related]
37. The Role of Neutrophil-to-lymphocyte Ratio on the Effect of CRT for Patients With Rectal Cancer.
Ishikawa D; Nishi M; Takasu C; Kashihara H; Tokunaga T; Higashijima J; Yoshikawa K; Shimada M
In Vivo; 2020; 34(2):863-868. PubMed ID: 32111796
[TBL] [Abstract][Full Text] [Related]
38. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
39. Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy.
Toiyama Y; Oki S; Okugawa Y; Ide S; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Inoue Y; Araki T; Kusunoki M
Oncology; 2018; 95(5):270-280. PubMed ID: 29996133
[TBL] [Abstract][Full Text] [Related]
40. Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery.
Toiyama Y; Inoue Y; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Saigusa S; Tanaka K; Mohri Y; Kusunoki M
Int Surg; 2015 Feb; 100(2):199-207. PubMed ID: 25692418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]